Tuberculosis and diabetes mellitus: Relating immune impact of co-morbidity with challenges in disease management in high burden countries
Open Access
- 29 November 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Abstract
No abstract availableKeywords
This publication has 81 references indexed in Scilit:
- Glycemic control among patients in China with type 2 diabetes mellitus receiving oral drugs or injectablesBMC Public Health, 2013
- Expression of M. tuberculosis-induced suppressor of cytokine signaling (SOCS) 1, SOCS3, FoxP3 and secretion of IL-6 associates with differing clinical severity of tuberculosisBMC Infectious Diseases, 2013
- A commentary on studies presenting projections of the future prevalence of dementiaBMC Public Health, 2013
- Diabetes and tuberculosis: a review of the role of optimal glycemic controlJournal of Diabetes & Metabolic Disorders, 2012
- Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomesThorax, 2012
- Prevalence of Diabetes and Pre-Diabetes and Associated Risk Factors among Tuberculosis Patients in IndiaPLOS ONE, 2012
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030Diabetes Research and Clinical Practice, 2011
- ESAT6-Induced IFNγ and CXCL9 Can Differentiate Severity of TuberculosisPLOS ONE, 2009
- Tuberculosis in Poorly Controlled Type 2 Diabetes: Altered Cytokine Expression in Peripheral White Blood CellsClinical Infectious Diseases, 2008
- Diabetes Mellitus Increases the Risk of Active Tuberculosis: A Systematic Review of 13 Observational StudiesPLoS Medicine, 2008